Stay updated on ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the usual study details, with a standard header/footer visible. This indicates an access or server issue preventing users from viewing the trial information on this page.
    Difference
    20%
    Check dated 2026-09-21T22:44:06.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.6, replacing the previous v3.6.5, indicating a newer page version. No substantive study details appear to be altered by this update.
    Difference
    0.0%
    Check dated 2026-08-31T16:45:55.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.5, representing a minor maintenance update to the study record rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-08-10T14:21:00.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.4. This administrative update does not change the study details or how the page is used by visitors.
    Difference
    0.0%
    Check dated 2026-07-27T06:28:21.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.2 to v3.6.3, indicating a minor backend or display update. The visible study information and user actions remain unchanged.
    Difference
    0.0%
    Check dated 2026-07-05T11:48:59.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    A broader set of keywords/MeSH terms and drug names was added to the study's metadata (e.g., Bevacizumab, Gemcitabine, Paclitaxel, Carboplatin, pegylated liposomal doxorubicin), enhancing indexing and cross-linking. The revision tag was updated from v3.6.0 to v3.6.2.
    Difference
    79%
    Check dated 2026-06-28T06:45:06.000Z thumbnail image

Stay in the know with updates to ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.